25 Posts Not to Miss from ESMO Congress 2026: Day 4
DeLLphi-304 Trial: Tarlatamab Versus Chemotherapy in SCLC
OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition Part 2
OptiTROP-Breast01 Final Analysis: Sacituzumab Tirumotecan Sustains Overall Survival Benefit in Previously Treated Metastatic Triple-Negative Breast Cancer
Gilberto Lopes: Key Insights from ESMO 2026
Amol Akhade: An Indian Phase III Trial With the Potential to Change Practice in Oral Cavity Cancer
Julie Gralow։ ESMO - ASCO Joint Session Explored the Evolving Definition of the Modern Oncologist
Toufic Kachaamy: Neoadjuvant Immunotherapy is Changing Colorectal Cancer Care
The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event, both onsite in London, UK, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect […]
The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC), scheduled for December 10, 2025, from 8:30 a.m. to 12:00 p.m. BST. This half-day primer, held at the Queen Elizabeth II Centre in London, UK, focuses on fundamental […]
The educational webinar titled "The Role of Modern Radiotherapy for Low Grade Glioma," part of the Educational Lectures on Paediatric Radiation Oncology Series, will be held virtually on December 11, 2025, at 16:00 CET (Central European Time). This open-to-all session will feature speaker Danny Indelicato, Professor in the Department of Radiation Oncology at the University […]
The webinar "Advancing Pediatric ALL Care: Adapting Global Standards for LMICs" will be held virtually on Thursday, December 11, 2025, at 2 PM CET/Geneva. This session focuses on sharing Global Updates and Future Directions in pediatric ALL care and specifically addressing how to translate and implement these advancements From Evidence to Practice in Resource-Limited Settings (LMICs), […]
"BMT Across the World: Who Makes What and Who Pays Whom?" is Part 1 of a joint educational series hosted by the ASTCT (American Society for Transplantation and Cellular Therapy) and the EBMT (European Society for Blood and Marrow Transplantation), scheduled for December 11, 2025, at 9:00 AM CST. Focusing on allogeneic Bone Marrow Transplantation […]
The 33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors is a two-day scientific meeting organized by the TTD Group (Digestive Tumor Treatment Group). The event will be […]
The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai, scheduled for December 13–14, 2025. This conference, hosted by the Global Healthcare Academy (GHA), is a major platform for disseminating the most recent, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress. Designed for a multidisciplinary […]
The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management, from diagnosis to treatment, according to current standards of care. Organized by the European Society for Medical Oncology (ESMO), the event is scheduled to take place on December 16–17, 2025, in Lugano, Switzerland. […]
The Oncology Nursing Society of Nigeria (ONSN) is hosting its 1st National Oncology Nursing Conference titled "Oncology Nursing in the Spotlight: Celebrating Excellence and Inspiring Growth." The conference is scheduled […]
The Digestive Oncology Autumn Symposium, Edition 2025, is scheduled for the afternoon of Tuesday, December 16, 2025, at Salons De Romree in Grimbergen, Belgium. The event will begin with a […]
The State of AI in Precision Oncology 2025 is the third annual, free virtual summit hosted by the journal AI in Precision Oncology, aiming to assess the current evolution of […]
The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17, 2025, at 18:00 CET. This free, open-to-all online event will feature experts from medical oncology, radiation oncology, and thoracic surgery who will explore and discuss the status of current as well as upcoming clinical trials focused […]
The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual, multi-stakeholder event scheduled for December 17, 2025, from 1:00 p.m. to 2:15 p.m. ET. The webinar will feature expert faculty, including Sid Devarakonda, MD, and Megan May, PharmD, to provide clinical insights into the use of […]
"Going Full TILt: challenges, successes, and coordination with administering TIL therapy" is an upcoming "Rx-cited: Clinical Conundrums" roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task Force, scheduled for Wednesday, December 17, 2025, from 2:00–3:00 PM CST. The session is designed to be an informal Q&A discussion focusing on the challenges, […]
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals […]
The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and […]
